logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 20 of 32 Items
Showing 1 - 20 of 32 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Using an analogue-digital hybrid clinical data management platform during a two-dose preventive Ebola virus vaccine trial in Goma, the Democratic Republic of the Congo

Brindle HE, Tetsa-Tata D, Edwards T, Choi EML, Kasonia K,  et al.
2025-05-02 • PLOS Global Public Health
2025-05-02 • PLOS Global Public Health

Clinical trials in settings with intermittent or non-existent internet and power connectivity, for example ...

Journal Article
|
Research

Evaluation of a decentralised model of care on case isolation and patient outcomes during the 2018–20 Ebola outbreak in the Democratic Republic of the Congo: a retrospective observational study

Barks PM, Camacho A, Newport T, Ribeiro F, Ahuka-Mundeke S,  et al.
2025-03-25 • Lancet Global Health
2025-03-25 • Lancet Global Health
Journal Article
|
Research

rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches)

Watson CH, Gsell PS, Hall Y, Camacho A, Riveros X,  et al.
2024-11-07 • BMC Medicine
2024-11-07 • BMC Medicine

BACKGROUND

Zaire Ebolavirus disease (EVD) outbreaks can be controlled using rVSV-ZEBOV vaccination and other public health measures. People in high-risk areas m...

Journal Article
|
Case Report/Series

Effectiveness of rVSV-ZEBOV vaccination during the 2018–20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative study

Meakin S, Nsio J, Camacho A, Kitenge R, Coulborn RM,  et al.
2024-08-01 • Lancet Infectious Diseases
2024-08-01 • Lancet Infectious Diseases

BACKRGOUND

The rec...

Journal Article
|
Commentary

Importance of investing time and money in integrating large language model-based agents into outbreak analytics pipelines

van Hoek AJ, Funk S, Flasche S, Quilty BJ, van Kleef E,  et al.
2024-08-01 • Lancet Microbe
2024-08-01 • Lancet Microbe
Journal Article
|
Research

Immunogenicity of an extended dose interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen in adults and children in the Democratic Republic of the Congo

Choi EM, Kasonia K, Kavunga-Membo H, Mukadi-Bamuleka D, Soumah A,  et al.
2024-07-26 • Vaccines
2024-07-26 • Vaccines

During the 2018–2020 Ebola virus disease outbreak in Democratic Republic of the Congo, a phase 3 trial of the Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine (DRC-EB-001) commenced in Goma, wit...

Journal Article
|
Research

Delivery and safety of a two-dose preventive Ebola virus disease vaccine in pregnant and non-pregnant participants during an outbreak in the Democratic Republic of the Congo

Kavunga-Membo H, Watson-Jones D, Kasonia K, Edwards T, Camacho A,  et al.
2024-07-23 • Vaccines
2024-07-23 • Vaccines

During the 2018–2020 Ebola virus disease (EVD) outbreak, residents in Goma, Democratic Republic of the Congo, were offered a two-dose prophylactic EVD vaccine. This was the first stud...

Conference Material
|
Poster

Unravelling the chains of transmission of the 9th Ebola outbreak in DRC, 2018

Soubrier H, Talla C, Gaye A, Mbala P, Van Herp M,  et al.
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
Conference Material
|
Poster

Real-time high resolution geo-spatial analysis of key indicators in a large-scale cholera outbreak in Port-au-Prince, Haiti, 2022-2023

Casera M, Lacan K, Camacho A, Augustin C, Métrailler F,  et al.
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024
Conference Material
|
Abstract

Interim results of the multi-site incidence study of Lassa fever in West Africa

Camacho A
2023-06-08 • Epicentre Scientific Day Paris 2023
2023-06-08 • Epicentre Scientific Day Paris 2023
BACKGROUND
Lassa fever (LF), a haemorrhagic illness caused by the Lassa fever virus (LASV), is endemic in West Africa causing an estimated 300 000 to 500 000 cases and 5 000 fataliti...
Conference Material
|
Video

Interim results of the multi-site incidence study of Lassa fever in West Africa

Camacho A
2023-06-08 • Epicentre Scientific Day Paris 2023
2023-06-08 • Epicentre Scientific Day Paris 2023
Journal Article
|
Protocol

A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)–Study protocol

Penfold S, Adegnika AA, Asogun D, Ayodeji O, Azuogu BN,  et al.
2023-03-30 • PLOS One
2023-03-30 • PLOS One
BACKGROUND
Lassa fever (LF), a haemorrhagic illness caused by the Lassa fever virus (LASV), is endemic in West Africa and causes 5000 fatalities every year. The true prevalence and i...
Conference Material
|
Slide Presentation

Breastfeeding promotion and support among infants aged less than six months in Maiduguri, Nigeria

Camacho A, Chara A, Htet Aung K, Hussein F, Nzala JC,  et al.
2022-12-01 • MSF Paediatric Days 2022
2022-12-01 • MSF Paediatric Days 2022
Conference Material
|
Abstract

Breastfeeding promotion and support among infants aged less than 6 months in Maiduguri, Nigeria: caregivers' and health workers' perspectives

Camacho A, Chara A, Htet Aung K, Hussein F, Nzala JC,  et al.
2022-11-26 • MSF Paediatric Days 2022
2022-11-26 • MSF Paediatric Days 2022
BACKGROUND AND AIMS
International guidelines on infant feeding in emergencies advise protecting, promoting, and supporting breastfeeding (BF) for all infants in these settings. The r...
Conference Material
|
Video

Modelling the cholera outbreak in Yemen

Camacho A
2018-06-07 • Epicentre Scientific Day 2018
2018-06-07 • Epicentre Scientific Day 2018
Journal Article
|
Pre-Print

Assessing the performance of real-time epidemic forecasts: A case study of Ebola in the Western Area Region of Sierra Leone, 2014-15

Funk S, Camacho A, Kucharski AJ, Lowe R, Eggo RM,  et al.
2017-08-18 • bioRxiv
2017-08-18 • bioRxiv
Real-time forecasts based on mathematical models can inform critical decision-making during infectious disease outbreaks. Yet, epidemic forecasts are rarely evaluated during or after the...
Conference Material
|
Video

Contribution of (new) technologies in epidemiology

Camacho A
2021-06-10 • Epicentre Scientific Day Paris 2021
2021-06-10 • Epicentre Scientific Day Paris 2021
Conference Material
|
Abstract

Modelling the cholera outbreak in Yemen

Camacho A
2018-06-07 • Epicentre Scientific Day 2018
2018-06-07 • Epicentre Scientific Day 2018
We modelled the plausible drivers of cholera transmission during the course of the outbreak in Yemen. We found a strong association between rainfall and the massive surge of cholera case...
Journal Article
|
Research

Control of Ebola virus disease outbreaks: Comparison of health care worker-targeted and community vaccination strategies

Robert A, Camacho A, Edmunds WJ, Baguelin M, Muyembe JJT,  et al.
2019-03-02 • Epidemics
2019-03-02 • Epidemics
Health care workers (HCW) are at risk of infection during Ebola virus disease outbreaks and therefore may be targeted for vaccination before or during outbreaks. The effect of these stra...
Journal Article
|
Research

Cholera epidemic in Yemen, 2016-18: an analysis of surveillance data

Camacho A, Bouhenia M, Alyusfi R, Alkohlani A, Naji MAM,  et al.
2018-05-03 • Lancet Global Health
2018-05-03 • Lancet Global Health
In war-torn Yemen, reports of confirmed cholera started in late September, 2016. The disease continues to plague Yemen today in what has become the largest documented cholera epidemic of...